Literature DB >> 16307628

The impact of clinical trials on the use of hormone replacement therapy. A population-based study.

Nancy Kim1, Cary Gross, Jeptha Curtis, Glen Stettin, Stephen Wogen, Nami Choe, Harlan M Krumholz.   

Abstract

BACKGROUND: The last 5 years of trial data demonstrate the ineffectiveness of hormone replacement therapy (HRT). The impact of these trials on age-specific HRT use, HRT discontinuation, and regional HRT variation has not been evaluated extensively.
OBJECTIVE: To characterize the relation between HRT trial dissemination and age-specific HRT use, HRT discontinuation, and regional HRT variation before and after the trials' publication.
DESIGN: Using the Medco Health database, we analyzed HRT prescription filling, discontinuation, and regional variation among women > or =55 years from May 1998 to May 2003.
MEASUREMENTS AND MAIN RESULTS: Approximately 340,000 women were eligible for Medco benefits each month. Within 3 months of the Women's Health Initiative (WHI), HRT prescriptions declined from 12.5% to 9.4%, P< or =.0001. When stratified by age, a statistically significant decline in HRT post-WHI occurred in all age groups, with the biggest decline among women > or =55 to 64 (18% to 11%, P< or =.0001). Among HRT users, we found statistically significant increases in discontinuation in 2002 (67%) compared with 2001 (53%, P<.0001). Prior to the WHI there was substantial regional variation in HRT use, with the West South Central and mid-Atlantic having the highest and lowest proportions, respectively (19% vs 6%, P< or =.0001). Despite a relative decline in HRT use of 25% to 42% across all regions, substantial geographic variation remained.
CONCLUSIONS: Hormone replacement therapy use decreased significantly immediately post-WHI, suggesting that trial results can have a rapid effect on practice. Marked regional variation in HRT use persisted after the WHI, suggesting that local practice patterns exert a strong effect on clinical behavior even after new evidence is available.

Entities:  

Mesh:

Year:  2005        PMID: 16307628      PMCID: PMC1490267          DOI: 10.1111/j.1525-1497.2005.0221.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  29 in total

1.  Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  L Mosca; P Collins; D M Herrington; M E Mendelsohn; R C Pasternak; R M Robertson; K Schenck-Gustafsson; S C Smith ; K A Taubert; N K Wenger
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

2.  Geographic variation in the rate of carotid endarterectomy in Canada.

Authors:  T E Feasby; H Quan; W A Ghali
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

Review 3.  The variability of female reproductive ageing.

Authors:  Egbert R te Velde; Peter L Pearson
Journal:  Hum Reprod Update       Date:  2002 Mar-Apr       Impact factor: 15.610

4.  A clinical trial of estrogen-replacement therapy after ischemic stroke.

Authors:  C M Viscoli; L M Brass; W N Kernan; P M Sarrel; S Suissa; R I Horwitz
Journal:  N Engl J Med       Date:  2001-10-25       Impact factor: 91.245

5.  Extent and sources of geographic variation in Medicare end-stage renal disease expenditures.

Authors:  R A Hirth; P J Tedeschi; J R Wheeler
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

6.  Relation between prepublication release of clinical trial results and the practice of carotid endarterectomy.

Authors:  C P Gross; C A Steiner; E B Bass; N R Powe
Journal:  JAMA       Date:  2000-12-13       Impact factor: 56.272

7.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

8.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

9.  Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Authors:  Deborah Grady; David Herrington; Vera Bittner; Roger Blumenthal; Michael Davidson; Mark Hlatky; Judith Hsia; Stephen Hulley; Alan Herd; Steven Khan; L Kristin Newby; David Waters; Eric Vittinghoff; Nanette Wenger
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  14 in total

1.  Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States.

Authors:  Hannah P Yang; William F Anderson; Philip S Rosenberg; Britton Trabert; Gretchen L Gierach; Nicolas Wentzensen; Kathleen A Cronin; Mark E Sherman
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

2.  Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy.

Authors:  Rowan T Chlebowski; Garnet Anderson; JoAnn E Manson; Mary Pettinger; Shagufta Yasmeen; Dorothy Lane; Robert D Langer; F Allan Hubbell; Anne McTiernan; Susan Hendrix; Robert Schenken; Marcia L Stefanick
Journal:  J Clin Oncol       Date:  2010-05-03       Impact factor: 44.544

3.  Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure.

Authors:  Paul J Hauptman; Mark A Schnitzler; Jason Swindle; Thomas E Burroughs
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

4.  Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.

Authors:  Joshua A Roth; Ruth Etzioni; Teresa M Waters; Mary Pettinger; Jacques E Rossouw; Garnet L Anderson; Rowan T Chlebowski; Joann E Manson; Mark Hlatky; Karen C Johnson; Scott D Ramsey
Journal:  Ann Intern Med       Date:  2014-05-06       Impact factor: 25.391

5.  Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages.

Authors:  Gretchen L Gierach; Ruth M Pfeiffer; Deesha A Patel; Amanda Black; Catherine Schairer; Abegail Gill; Louise A Brinton; Mark E Sherman
Journal:  Menopause       Date:  2014-06       Impact factor: 2.953

6.  Probable tacrolimus toxicity from tibolone co-administration in a woman: a case report.

Authors:  Carolyn J Clark; Carmel M Hawley; David W Mudge
Journal:  J Med Case Rep       Date:  2010-08-19

Review 7.  Why do stress and urge incontinence co-occur much more often than expected?

Authors:  Vatche A Minassian; Walter F Stewart; Annemarie G Hirsch
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06-05

8.  How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes.

Authors:  Terry M Bush; Amy E Bonomi; Larissa Nekhlyudov; Evette J Ludman; Susan D Reed; Maureen T Connelly; Lou C Grothaus; Andrea Z LaCroix; Katherine M Newton
Journal:  J Gen Intern Med       Date:  2007-07-18       Impact factor: 5.128

9.  Determinants of hormone therapy discontinuation among female veterans nationally.

Authors:  Sally G Haskell; Bevanne Bean-Mayberry; Joseph L Goulet; Melissa Skanderson; Chester B Good; Amy C Justice
Journal:  Mil Med       Date:  2008-01       Impact factor: 1.437

10.  Effectiveness of yoga for menopausal symptoms: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Holger Cramer; Romy Lauche; Jost Langhorst; Gustav Dobos
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-07       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.